ISL1 promotes enzalutamide resistance in castration-resistant prostate cancer (CRPC) through epithelial to mesenchymal transition (EMT).
Sci Rep
; 11(1): 21984, 2021 11 09.
Article
in En
| MEDLINE
| ID: mdl-34753990
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phenylthiohydantoin
/
Transcription Factors
/
Benzamides
/
Drug Resistance, Neoplasm
/
Epithelial-Mesenchymal Transition
/
LIM-Homeodomain Proteins
/
Prostatic Neoplasms, Castration-Resistant
/
Androgen Antagonists
/
Antineoplastic Agents
/
Nitriles
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Sci Rep
Year:
2021
Type:
Article